Table 2.
>3-month retention | >6-month retention | |||
OR (95% CI) | p value | OR (95% CI) | p value | |
Age (>40 vs. ≤40 years) | 2.47 (1.62–3.77) | <0.001 | 1.89 (1.27–2.81) | 0.002 |
2.38 (1.54–3.67) | <0.001 | 2.04 (1.37–3.04) | <0.001 | |
Age (cont. variable) | 1.07 (1.04–1.10) | <0.001 | 1.06 (1.03–1.08) | <0.001 |
1.07 (1.04–1.10) | <0.001 | 1.06 (1.03–1.08) | <0.001 | |
Gender (male vs. female) | 0.98 (0.29–3.33) | 0.974 | 1.57 (0.56–4.43) | 0.385 |
1.14 (0.34–3.89) | 0.830 | 1.86 (0.67–5. 24) | 0.224 | |
Socially vulnerable | 1.20 (0.73–1.97) | 0.463 | 1.35 (0.83–2.21) | 0.232 |
1.18 (0.71–1.98) | 0.519 | 1.21 (0.75–1.96) | 0.433 | |
Hepatitis C status | 1.45 (0.97–2.17) | 0.071 | 1.43 (0.97–2.11) | 0.072 |
1.25 (0.83–1.90) | 0.281 | 1.02 (0.69–1.51) | 0.908 | |
HIV status | 0.82 (0.31–2.18) | 0.702 | 0.78 (0.33–1.85) | 0.583 |
0.73 (0.28–1.93) | 0.528 | 0.61(0.26–1.44) | 0.265 | |
>9-month retention | >12-month retention | |||
Age (>40 vs. ≤40 years) | 2.23 (1.46–3.41) | <0.001 | 2.49 (1.62–3.83) | <0.001 |
2.41(1.59–3.66) | <0.001 | 2.44 (1.59–3.73) | <0.001 | |
Age (cont. variable) | 1.07 (1.04–1.10) | <0.001 | 1.07 (1.04–1.10) | <0.001 |
1.07 (1.05–1.10) | <0.001 | 1.08 (1.05–1.11) | <0.001 | |
Gender | 3.21 (1.28–8.07) | 0.013 | 2.46 (0.95–6.41) | 0.065 |
3.69 (1.49–9.14) | 0.005 | 2.89 (1.13–7.43) | 0.027 | |
Socially vulnerable | 1.19 (0.72–1.98) | 0.487 | 1.14 (0.69–1.86) | 0.612 |
1.17 (0.71–1.92) | 0.534 | 1.18 (0.72–1.93) | 0.515 | |
Hepatitis C status | 1.73 (1.15–2.63) | 0.009 | 1.76 (1.15–2.67) | 0.009 |
1.18 (0.79–1.78) | 0.403 | 1.23 (0.82–1.86) | 0.318 | |
HIV status | 0.77 (0.32–1.82) | 0.550 | 1.14 (0.42–3.07) | 0.797 |
0.61 (0.26–1.45) | 0.265 | 0.89 (0.33–2.39 ) | 0.816 |
Age (cont. variable) analysis “age” as a continious variable i.e. examains the retention per each year increase in age